|
Real-time Estimate
Other stock markets
|
5-day change | 1st Jan Change | ||
| 61.72 USD | +4.55% |
|
+3.46% | -24.04% |
| 07-31 | Mizuho Trims Price Target on Tarsus Pharmaceuticals to $98 From $100, Keeps Outperform Rating | MT |
| 07-15 | RxSight Names Aziz Mottiwala as CEO | MT |
| Market Cap | 2.54B 2.21B 2.06B 1.89B 3.56B 242B 3.62B 24.23B 9.51B 121B 9.54B 9.33B 405B | P/E 2026 * |
-26.7x | P/E 2027 * | 23.8x |
|---|---|---|---|---|---|
| Enterprise Value | 2.54B 2.21B 2.06B 1.89B 3.56B 242B 3.62B 24.23B 9.51B 121B 9.54B 9.33B 405B | EV / Sales 2026 * |
3.56x | EV / Sales 2027 * | 2.82x |
| Free-Float |
96.94% | Yield 2026 * |
-
| Yield 2027 * | - |
Last Transcript: Tarsus Pharmaceuticals, Inc.
| 1 day | +4.43% | ||
| 1 week | +3.46% | ||
| Current month | +5.35% | ||
| 1 month | -7.23% | ||
| 3 months | -3.67% | ||
| 6 months | -6.97% | ||
| Current year | -24.04% |
| 1 week | 57.09 |  | 62.28 |
| 1 month | 53.89 | | 72.5 |
| Current year | 53.89 | | 83.92 |
| 1 year | 39.79 | | 85.25 |
| 3 years | 12.57 | | 85.25 |
| 5 years | 10.8 | | 85.25 |
| 10 years | 10.8 | | 85.25 |
| Manager | Title | Age | Since |
|---|---|---|---|
Bobak Azamian
CEO | Chief Executive Officer | 48 | 01/09/2018 |
Jeffrey Farrow
DFI | Director of Finance/CFO | 64 | 24/04/2023 |
| Chief Tech/Sci/R&D Officer | 47 | 04/11/2024 |
| Director | Title | Age | Since |
|---|---|---|---|
Bobak Azamian
CHM | Chairman | 48 | 02/12/2022 |
| Director/Board Member | 71 | 01/12/2019 | |
Bill Link
BRD | Director/Board Member | 80 | 01/01/2017 |
| Date | Insider | Type | Main position | Quantity | % Market Cap. | |
|---|---|---|---|---|---|---|
| 3/17/26 A | Sell | Chief Financial Officer | 6,430 | 0.0151% | ||
| 3/17/26 A | Sell | General Counsel | 12,440 | 0.0292% | ||
| 3/15/26 A | Fiscal year | Chief Operating Officer | 52,574 | 0.1235% |
| Change | 5-day change | 1-year change | 3-year change | Capi.($) | ||
|---|---|---|---|---|---|---|
 | +4.52% | +3.46% | +48.41% | +258.92% | 2.54B | |
| +0.26% | +14.81% | +34.02% | -0.71% | 76.15B | |
| -0.67% | -9.72% | +20.17% | +180.04% | 48.89B | |
| -4.18% | +42.30% | +42.30% | +42.30% | 47.83B | |
| +1.01% | +8.83% | -52.93% | -53.63% | 41.37B | |
| -0.24% | +1.48% | +53.64% | -24.14% | 29.99B | |
| -0.03% | +0.89% | +53.68% | +84.56% | 24.23B | |
| +3.11% | +2.33% | +105.96% | -48.22% | 21.89B | |
| -0.81% | -4.39% | -7.53% | +165.02% | 19.25B | |
| -7.35% | -5.91% | +61.82% | +113.39% | 17.14B | |
| Average | -0.49% | +0.97% | +35.96% | +71.75% | 32.93B | |
| Weighted average by Cap. | -0.82% | +2.34% | +29.39% | +44.34% |
| 2026 * | 2027 * | |
|---|---|---|
| Net sales | 714M 621M 578M 531M 1B 68.18B 1.02B 6.81B 2.67B 33.94B 2.68B 2.62B 114B | 900M 783M 728M 669M 1.26B 85.94B 1.28B 8.59B 3.37B 42.79B 3.38B 3.31B 143B |
| Net income | -98.78M -85.87M -79.93M -73.38M -139M -9.43B -141M -942M -370M -4.69B -371M -363M -15.74B | 138M 120M 112M 103M 194M 13.18B 197M 1.32B 517M 6.56B 519M 507M 22.01B |
| Net Debt | - | - |
| Date | Price | Change | Volume |
|---|---|---|---|
| 03/08/26 | $62.12 | +5.22% | 186,383 |
| 31/07/26 | $59.04 | -0.84% | 637,030 |
| 30/07/26 | $59.54 | +1.74% | 699,198 |
| 29/07/26 | $58.52 | -0.73% | 679,842 |
| 28/07/26 | $58.95 | -1.95% | 510,219 |
Trader
This super rating is the result of a weighted average of the rankings based on the following ratings: Valuation (Composite), EPS Revisions (4 months), and Visibility (Composite). We recommend that you carefully review the associated descriptions.
Investor
This super composite rating is the result of a weighted average of the rankings based on the following ratings: Fundamentals (Composite), Valuation (Composite), EPS Revisions (1 year), and Visibility (Composite). We recommend that you carefully review the associated descriptions.
Global
This composite rating is the result of an average of the rankings based on the following ratings: Fundamentals (Composite), Valuation (Composite), Financial Estimates Revisions (Composite), Consensus (Composite) and Visibility (Composite). The company must be covered by at least 4 of these 5 ratings for the calculation to be carried out. We recommend that you carefully review the associated descriptions.
Quality
This composite rating is the result of an average of rankings based on the following ratings: Returns (Composite), Profitability (Composite) and Quality of Financial Reporting (Composite), and Financial Health (Composite). The company must be covered by at least 2 of these 3 ratings for the calculation to be performed. We recommend that you carefully read the associated descriptions.
ESG MSCI
The MSCI ESG score assesses a company’s environmental, social, and governance practices relative to its industry peers. Companies are rated from CCC (laggard) to AAA (leader). This rating helps investors incorporate sustainability risks and opportunities into their investment decisions.
Quarterly revenue - Rate of surprise
- Stock Market
- Stocks
- TARS Stock
Select your edition
All financial news and data tailored to specific country editions
